Open Nav

Emmyon, Inc.

  • Chris Adams, Emmyon, Inc.

Biotechnology company investigating how aging, illness, and injury cause muscle atrophy and utilizing research data to identify molecules that augment muscle strength, mass, and metabolism. These patented molecules are developed by conducting biopsies to determine the microRNA expressions that cause muscle atrophy and match small molecule atrophy inhibitors. The applications of these molecules are the promotion of muscle health, as well as treatment for obesity and Type II Diabetes through the increase is skeletal muscle mass, which helps burn calories and increase resting energy expenditure.

  • Date:Wednesday, July 10
  • Time:10:30 AM - 10:45 AM
  • Room:Booth 400
  • Location:Booth 400, Exhibition Hall
  • Session Type:Start-Up Stadium
Chris Adams
Emmyon, Inc.